The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Polo-like kinase-1 as a potential prognostic marker of prostate cancer utilizing ORIEN data.
 
Snigdha Nutalapati
No Relationships to Disclose
 
Chi Wang
No Relationships to Disclose
 
Alice X Liu
No Relationships to Disclose
 
Zhuwei Zhang
No Relationships to Disclose
 
Howard Colman
No Relationships to Disclose
 
Elaine T. Lam
Consulting or Advisory Role - Calithera Biosciences
Research Funding - Advaxis (Inst); Amgen (Inst); Argos Therapeutics (Inst); Arrowhead Pharmaceuticals (Inst); Astellas Pharma (Inst); Biosplice (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Constellation Pharmaceuticals (Inst); Decibel Therapeutics (Inst); Exelixis (Inst); FORMA Therapeutics (Inst); Harpoon Therapeutics (Inst); Merck (Inst); OnQuality Pharmaceuticals (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Phosplatin Therapeutics (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Decibel Therapeutics
 
John D. Carpten
Honoraria - Roche
Consulting or Advisory Role - Bristol Meyer Squibb; Roche/Genentech; Roche/Genentech
Patents, Royalties, Other Intellectual Property - Methods related to Precision Medicine Know-How.; Royalty for IP (USC 2018-116) from drug licensed by Bridgene Biosciences, Inc.
Other Relationship - M2Gen
 
Eric A. Singer
Consulting or Advisory Role - Aura Biosciences; Johnson & Johnson/Janssen; Merck; Vyriad
Research Funding - Astellas Medivation
 
Nabil Adra
Consulting or Advisory Role - Astellas Pharma; Aveo; Bristol Myers Squibb Foundation; Bristol Myers Squibb Foundation; Exelixis; Merck; Sanofi
Research Funding - Exelixis (Inst); Genentech (Inst); Merck (Inst); Natera (Inst)
 
Michael Edward Devitt
Consulting or Advisory Role - Astellas Pharma; Seagen
Research Funding - Arvinas (Inst); Kangpu Biopharmaceuticals (Inst); Propella Therapeutics (Inst); Propella Therapeutics (Inst); Seagen (Inst); Syneos Health (Inst); Veru (Inst)
 
Jad Chahoud
Consulting or Advisory Role - AVEO; DAVA Pharmaceuticals; Exelixis; Pfizer
 
Abhishek Tripathi
Honoraria - Cardinal Health; Targeted Oncology; Urology times
Consulting or Advisory Role - Deka Biosciences; EMD Serono; Exelixis; Exelixis; Foundation Medicine; Genzyme; Pfizer; Seagen
Research Funding - Aravive (Inst); Bayer (Inst); Bayer (Inst); Clovis Oncology (Inst); Corvus Pharmaceuticals (Inst); EMD Serono (Inst); Exact Sciences (Inst); Exelixis (Inst); Pfizer (Inst); WindMIL (Inst)
 
Kelly Lynn Stratton
Honoraria - Bayer; Dendreon (Inst); Janssen; Johnson & Johnson/Janssen; Merck; MJH Life Sciences; Oakstone Publishing; Oakstone Publishing (Inst); Sun Pharma; Urology times
Consulting or Advisory Role - AMRO Pharma (Inst); Bayer (Inst); Bayer (Inst); Clovis Oncology (Inst); Dendreon (Inst); Large Urology Group Practice Association (Inst); Myriad Genetics (Inst); Sanofi (Inst)
Speakers' Bureau - Arkansas Urology; Bayer
Research Funding - Advantage Pharmaceuticals (Inst); Alliance Foundation Trials (Inst); Anchiano (Inst); Astellas ENACT CTA (Inst); Astellas Pharma (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Dendreon (Inst); EMD Serono (Inst); EMD Serono (Inst); Ferring (Inst); Genentech (Inst); Myovant Sciences (Inst); Myriad Genetics (Inst); Myriad Genetics (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Roche/Genentech (Inst); RTOG (Inst); TARIS Biomedical (Inst); TARIS Biomedical (Inst)
Travel, Accommodations, Expenses - Dendreon; Dendreon (Inst); Myriad Genetics
 
Zin Myint
Consulting or Advisory Role - EMD Serono